Trio exome sequencing as the stand-alone first-tier testing for prenatal diagnosis
Li, H.; Yan, L.; Zhang, Y.; Li, M.; Xue, J.; Tian, L.; Cao, J.; Wu, S.; Dong, Y.; Zhu, Y.; Zhou, H.; Shen, S.; Xu, X.; Shen, G.; Shen, X.; Chen, P.; Xu, Y.; Cai, D.; Wang, Y.; Liang, D.; Fang, S.; Chen, C.; Zheng, Z.; Geng, J.
Show abstract
BACKGROUNDWhole exome sequencing (WES) is increasingly utilized in prenatal diagnosis of fetus with structural abnormality. However, evidence supporting its use as a first-tier genetic test for all pregnancies referred for invasive prenatal procedures remains limited. METHODSWe conducted a multi-center prospective study enrolling 1,382 pregnancies from seven prenatal diagnosis centers all around China. Participants were divided into two groups based on clinical indications: those for whom CMA testing was traditionally recommended (CMA group) and those for whom CMA and WES were sequentially or concurrently recommended (CTW group) according to their indications. After excluding 200 pregnancies terminated prior to genetic test reporting, the cohort included 1,182 cases undergoing independent trio-WES and CMA testing. The primary outcome was determined through follow-up of at least 3 months after delivery. RESULTSTrio-WES yielded an overall diagnostic yield of 17.22%, with an incremental yield of 7.38% for SNVs/Indels not detected by CMA. Even for subjects in the CMA group, theres a diagnostic yield of 4.02%, arising from SNVs/Indels that would be missed by CMA. Trio-WES showed a 100% concordance with CMA on detection of reportable cytogenomic events, with unique advantages over CMA in 6 cases with UPD and 3 cases with exon-level deletion. Importantly, WES results, whether positive, negative or uncertain, significantly impact clinical decision-making for pregnancy. CONCLUSIONSOur findings support the use of prenatal trio-WES as a stand-alone first-tier genetic test for all pregnancies referred for invasive prenatal diagnosis, regardless of indication.
Matching journals
The top 3 journals account for 50% of the predicted probability mass.
Similar papers in this journal
- The Human Intolerome: a curated database to prioritize genomic variants in stillbirth, pregnancy loss, and neonatal death 95%
- Whole-exome sequencing analysis on products of conception: A cohort study to evaluate clinical utility and genetic etiology for pregnancy loss 94%
- Comprehensive phenotyping of 3q29 deletion syndrome: recommendations for clinical care 92%
Similar papers in this journal
- Exome copy number variant detection, analysis and classification in a large cohort of families with undiagnosed rare genetic disease 93%
- Returning Actionable Genomic Results in a Research Biobank: Analytic Validity, Clinical Implementation and Resource Utilization 93%
- Inherited infertility - mapping loci associated with impaired female reproduction 92%
Similar papers in this journal
- Long-read genome sequencing for the diagnosis of neurodevelopmental disorders 91%
- Identification and validation of novel candidate risk genes in endocytic vesicular trafficking associated with esophageal atresia and tracheoesophageal fistulas 91%
- Whole Genome Sequencing for the Diagnosis of Rare Disorders 90%
Similar papers in this journal
- Genetic Diagnosis of Facioscapulohumeral Muscular Dystrophy Type 1 Using Rare Variant Linkage Analysis and Long Read Genome Sequencing 92%
- 3-hour genome sequencing and targeted analysis to rapidly assess genetic risk 91%
- Detection and characterisation of copy number variants from exome sequencing in the DDD study 89%
Similar papers in this journal
- Exome sequencing as a first-tier test for copy number variant detection : retrospective evaluation and prospective screening in 2418 cases 93%
- Disease-specific variant interpretation highlighted the genetic findings in 2325 Japanese patients with retinitis pigmentosa and allied diseases 90%
- Assessing performance of pathogenicity predictors using clinically-relevant variant datasets 89%
"Similar papers" are the closest papers from that journal in the model's embedding space. They show what the match is built on, but the ranking comes mostly from a classifier over the whole training set, not from these examples alone.